Answers are grounded in this paper and cite their sources.
High CD3 and CD8 mRNA expression in early-stage breast cancer patients is of prognostic value for decreased risk of relapse and, in the future, could potentially be of importance in deciding the most appropriate therapeutic strategy in light of the recent immune-related treatment developments.
No takes yet. Share an insight, caveat, or question.
Tsiatas et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: